BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26687858)

  • 1. Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia.
    Eisenmenger LB; Huo EJ; Hoffman JM; Minoshima S; Matesan MC; Lewis DH; Lopresti BJ; Mathis CA; Okonkwo DO; Mountz JM
    Semin Nucl Med; 2016 Jan; 46(1):57-87. PubMed ID: 26687858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain PET in suspected dementia: patterns of altered FDG metabolism.
    Brown RK; Bohnen NI; Wong KK; Minoshima S; Frey KA
    Radiographics; 2014; 34(3):684-701. PubMed ID: 24819789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
    Atri A
    Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-specific PET probes for neurodegenerative disorders related to dementia.
    Kadir A; Nordberg A
    J Nucl Med; 2010 Sep; 51(9):1418-30. PubMed ID: 20810758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
    Silverman DH
    J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.
    Del Sole A; Malaspina S; Magenta Biasina A
    Funct Neurol; 2016; 31(4):205-215. PubMed ID: 28072381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and degenerative disorders primarily causing dementia.
    Masdeu JC; Pascual B
    Handb Clin Neurol; 2016; 135():525-564. PubMed ID: 27432682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Neurodegenerative Disorders with Amyloid-β, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls.
    Burkett BJ; Johnson DR; Lowe VJ
    J Nucl Med; 2024 Jun; 65(6):829-837. PubMed ID: 38664015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of PET neuroimaging.
    Nasrallah I; Dubroff J
    Semin Nucl Med; 2013 Nov; 43(6):449-61. PubMed ID: 24094712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures.
    Grassetto G; Marzola MC; Musto A; Viniamury S; Colletti PM; Perkins AC; Rubello D
    Nucl Med Commun; 2014 Nov; 35(11):1085-92. PubMed ID: 25162962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET Imaging of Dementia: Update 2022.
    Burkett BJ; Babcock JC; Lowe VJ; Graff-Radford J; Subramaniam RM; Johnson DR
    Clin Nucl Med; 2022 Sep; 47(9):763-773. PubMed ID: 35543643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of brain amyloid in dementia: a review.
    Quigley H; Colloby SJ; O'Brien JT
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of molecular imaging (PET) in the diagnostics of dementia].
    Tscheuschler M; Gebest M; Jessen F; Drzezga A
    Nervenarzt; 2018 Jul; 89(7):843-856. PubMed ID: 29916030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia.
    Ricci M; Cimini A; Chiaravalloti A; Filippi L; Schillaci O
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
    Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
    J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Amyloid Imaging.
    Mallik A; Drzezga A; Minoshima S
    Semin Nucl Med; 2017 Jan; 47(1):31-43. PubMed ID: 27987555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.